Kyung Hwan Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kyung Hwan Kim has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Han-Joo Lee
Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea
7 shared publications Hyeon-Song Koh
Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, South Korea
6 shared publications- Seon-Hwan Kim
Department of Neurosurgery, Institute for Cancer Research, College of Medicine, Chungnam National University, Daejeon, Republic of Korea
6 shared publications Seung-Won Choi
Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, South Korea
6 shared publicationsHyon-Jo Kwon
Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, South Korea
5 shared publicationsJin-Young Youm
5 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (7) , 102850
Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma
- 11 June 2026
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (7) , 102850
Open AccessPatient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma
- 12 May 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 402
Feasibility of short-course antibiotic therapy for surgically treated brain abscess guided by 4-week MRI
Brain abscess is a life-threatening intracranial infection typically managed with surgery followed by prolonged intravenous antibiotics. This study aimed to evaluate the feasibility of a short-course intravenous antibiotics regimen after surgery and to assess the utility of 4-week MRI as a biomarker to guide treatment discontinuation. This retrospective study included 60 patients who underwent surgery for bacterial brain abscess at a tertiary center between 2011 and 2024. A scheduled 4-week MRI including diffusion-weighted imaging was performed to assess radiologic resolution. The clinical outcomes, including recurrence, treatment-related adverse events (AEs), and 6-month functional outcomes, were investigated. Patients were categorized into short-course and conventional groups according to antibiotic duration (< 35 vs. ≥35 days), based on the cut-off value for predicting the development of severe AEs. There was no recurrence in both groups. Severe AEs occurred in 22 patients (36.7%), and the most common severe AE was neutropenia followed by severe drug eruption. Patients in the short-course group had significantly fewer severe AEs (P = 0.007) and better functional outcomes at 6 months (P = 0.032) compared to the conventional group. Prolonged antibiotic use was the only independent risk factor for severe AEs (P = 0.036). 4-week MRI was performed in 42 patients (70.0%), and all 25 patients in the short-course group underwent the 4-week MRI and met the resolution criteria. A short-course intravenous antibiotics therapy following surgical evacuation was effective and safe when guided by MRI at 4 weeks, which served as a reliable indicator to confirm resolution and safe treatment discontinuation.
- 12 May 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 402
Feasibility of short-course antibiotic therapy for surgically treated brain abscess guided by 4-week MRI
Brain abscess is a life-threatening intracranial infection typically managed with surgery followed by prolonged intravenous antibiotics. This study aimed to evaluate the feasibility of a short-course intravenous antibiotics regimen after surgery and to assess the utility of 4-week MRI as a biomarker to guide treatment discontinuation. This retrospective study included 60 patients who underwent surgery for bacterial brain abscess at a tertiary center between 2011 and 2024. A scheduled 4-week MRI including diffusion-weighted imaging was performed to assess radiologic resolution. The clinical outcomes, including recurrence, treatment-related adverse events (AEs), and 6-month functional outcomes, were investigated. Patients were categorized into short-course and conventional groups according to antibiotic duration (< 35 vs. ≥35 days), based on the cut-off value for predicting the development of severe AEs. There was no recurrence in both groups. Severe AEs occurred in 22 patients (36.7%), and the most common severe AE was neutropenia followed by severe drug eruption. Patients in the short-course group had significantly fewer severe AEs (P = 0.007) and better functional outcomes at 6 months (P = 0.032) compared to the conventional group. Prolonged antibiotic use was the only independent risk factor for severe AEs (P = 0.036). 4-week MRI was performed in 42 patients (70.0%), and all 25 patients in the short-course group underwent the 4-week MRI and met the resolution criteria. A short-course intravenous antibiotics therapy following surgical evacuation was effective and safe when guided by MRI at 4 weeks, which served as a reliable indicator to confirm resolution and safe treatment discontinuation.
- Open Access
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (3) , 802-811
Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation
Background: Glioblastoma multiforme (GBM) is the most lethal type of primary brain tumor, necessitating the discovery of reliable serum prognostic biomarkers. This study aimed to investigate the prognostic value of serum Interleukin-6 (IL-6) in GBM patients.
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (3) , 802-811
Open AccessElevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation
Background: Glioblastoma multiforme (GBM) is the most lethal type of primary brain tumor, necessitating the discovery of reliable serum prognostic biomarkers. This study aimed to investigate the prognostic value of serum Interleukin-6 (IL-6) in GBM patients.
- Open Access
- 30 June 2024
- Published by The Korean Society of Geriatric Neurosurgery in Journal of Korean Society of Geriatric Neurosurgery
- Vol. 20 (1) , 14-20
Concurrent chemoradiation therapy for improving survival in older patients with glioblastoma: a narrative review
Despite the establishment of standard treatments for glioblastoma, the efficacy of concurrent chemoradiation therapy (CCRT) for older patients remains a matter of debate, even with the insights from recent randomized trials. This study offers an updated, evidence-based review of contemporary management using CCRT in older glioblastoma patients. Treating older glioblastoma patients necessitates a tailored approach, prioritizing individual patient needs. Additionally, this study emphasizes the efficacy of short-course CCRT, which has been confirmed through recent randomized trials.
- 30 June 2024
- Published by The Korean Society of Geriatric Neurosurgery in Journal of Korean Society of Geriatric Neurosurgery
- Vol. 20 (1) , 14-20
Open AccessConcurrent chemoradiation therapy for improving survival in older patients with glioblastoma: a narrative review
Despite the establishment of standard treatments for glioblastoma, the efficacy of concurrent chemoradiation therapy (CCRT) for older patients remains a matter of debate, even with the insights from recent randomized trials. This study offers an updated, evidence-based review of contemporary management using CCRT in older glioblastoma patients. Treating older glioblastoma patients necessitates a tailored approach, prioritizing individual patient needs. Additionally, this study emphasizes the efficacy of short-course CCRT, which has been confirmed through recent randomized trials.
- Open Access
- 1 January 2024
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 20 (4) , 303-304
Letter to the Editor: Commentary on Feasibility Study of Parkinson’s Speech Disorder Evaluation With Pre-Trained Deep Learning Model for Speech-to-Text Analysis (Korean J Neurotrauma 2024;20:168-179)
Kim KH. Korean J Neurotrauma. 2024 Dec;20:e40. https://doi.org/10.13004/kjnt.2024.20.e40
- 1 January 2024
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 20 (4) , 303-304
Open AccessLetter to the Editor: Commentary on Feasibility Study of Parkinson’s Speech Disorder Evaluation With Pre-Trained Deep Learning Model for Speech-to-Text Analysis (Korean J Neurotrauma 2024;20:168-179)
Kim KH. Korean J Neurotrauma. 2024 Dec;20:e40. https://doi.org/10.13004/kjnt.2024.20.e40
- Open Access
- 9 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Efficacy of hydroxyapatite-based skull base reconstruction for intraoperative high-flow cerebrospinal fluid leakage performed by less-experienced surgeons
Cerebrospinal fluid (CSF) leakage after endoscopic skull base surgery remains a challenge despite multilayer reconstruction including nasoseptal flap (NSF) has become a standard technique. Injectable hydroxyapatite (HXA) has shown promising results to prevent CSF leakage. This study aimed to validate the efficacy of HXA-based skull base reconstruction performed by less-experienced neurosurgeons who had short-term clinical experiences as independent surgeons. Between March 2018 and November 2022, 41 patients who experienced intraoperative high-flow CSF leakage following endoscopic endonasal surgery at two independent tertiary institutions were enrolled. Skull base reconstruction was performed using conventional multilayer techniques combined with or without HXA. The primary outcome was postoperative CSF leakage. The surgical steps and nuances were described in detail. The most common pathology was craniopharyngioma. Injectable HXA was used in 22 patients (HXA group) and conventional techniques were performed in 19 patients (control group). The HXA group achieved a significantly lower incidence of postoperative CSF leakage than the control group (0% vs. 26.3%, p = 0.016). No HXA-related complications were observed. The use of injectable HXA in skull base reconstruction was highly effective and safe. This technique and its favorable results might be readily reproduced by less-experienced neurosurgeons.
- 9 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Open AccessEfficacy of hydroxyapatite-based skull base reconstruction for intraoperative high-flow cerebrospinal fluid leakage performed by less-experienced surgeons
Cerebrospinal fluid (CSF) leakage after endoscopic skull base surgery remains a challenge despite multilayer reconstruction including nasoseptal flap (NSF) has become a standard technique. Injectable hydroxyapatite (HXA) has shown promising results to prevent CSF leakage. This study aimed to validate the efficacy of HXA-based skull base reconstruction performed by less-experienced neurosurgeons who had short-term clinical experiences as independent surgeons. Between March 2018 and November 2022, 41 patients who experienced intraoperative high-flow CSF leakage following endoscopic endonasal surgery at two independent tertiary institutions were enrolled. Skull base reconstruction was performed using conventional multilayer techniques combined with or without HXA. The primary outcome was postoperative CSF leakage. The surgical steps and nuances were described in detail. The most common pathology was craniopharyngioma. Injectable HXA was used in 22 patients (HXA group) and conventional techniques were performed in 19 patients (control group). The HXA group achieved a significantly lower incidence of postoperative CSF leakage than the control group (0% vs. 26.3%, p = 0.016). No HXA-related complications were observed. The use of injectable HXA in skull base reconstruction was highly effective and safe. This technique and its favorable results might be readily reproduced by less-experienced neurosurgeons.
- 6 August 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 51 (3) , 231-235
Distal stenting technique for coil embolization of early branch aneurysms of middle cerebral artery
- 6 August 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 51 (3) , 231-235
Distal stenting technique for coil embolization of early branch aneurysms of middle cerebral artery
- Open Access
- 21 March 2023
- Published by Springer Nature in Research Square
Efficacy of hydroxyapatite-based skull base reconstruction for intraoperative high-flow cerebrospinal fluid leakage performed by less-experienced surgeons: a two-institution study
Cerebrospinal fluid (CSF) leakage after endoscopic skull base surgery remains a challenge despite multilayer reconstruction including nasoseptal flap (NSF) has become a standard technique. Injectable hydroxyapatite (HXA) has shown promising results to prevent CSF leakage. This study aimed to validate the efficacy of HXA-based skull base reconstruction performed by less-experienced neurosurgeons who had short-term clinical experiences as independent surgeons. Between March 2018 and November 2022, 41 patients who experienced intraoperative high-flow CSF leakage following endoscopic endonasal surgery at two independent tertiary institutions were enrolled. Skull base reconstruction was performed using conventional multilayer techniques combined with or without HXA. The primary outcome was postoperative CSF leakage. The surgical steps and nuances were described in detail. The most common pathology was craniopharyngioma. Injectable HXA was used in 22 patients (HXA group) and conventional techniques were performed in 19 patients (control group). The HXA group achieved a significantly lower incidence of postoperative CSF leakage than the control group (0% vs. 26.3%, p = 0.016). No HXA-related complications were observed. The use of injectable HXA in skull base reconstruction was highly effective and safe. This technique and its favorable results might be readily reproduced by less-experienced neurosurgeons.
- 21 March 2023
- Published by Springer Nature in Research Square
Open AccessEfficacy of hydroxyapatite-based skull base reconstruction for intraoperative high-flow cerebrospinal fluid leakage performed by less-experienced surgeons: a two-institution study
Cerebrospinal fluid (CSF) leakage after endoscopic skull base surgery remains a challenge despite multilayer reconstruction including nasoseptal flap (NSF) has become a standard technique. Injectable hydroxyapatite (HXA) has shown promising results to prevent CSF leakage. This study aimed to validate the efficacy of HXA-based skull base reconstruction performed by less-experienced neurosurgeons who had short-term clinical experiences as independent surgeons. Between March 2018 and November 2022, 41 patients who experienced intraoperative high-flow CSF leakage following endoscopic endonasal surgery at two independent tertiary institutions were enrolled. Skull base reconstruction was performed using conventional multilayer techniques combined with or without HXA. The primary outcome was postoperative CSF leakage. The surgical steps and nuances were described in detail. The most common pathology was craniopharyngioma. Injectable HXA was used in 22 patients (HXA group) and conventional techniques were performed in 19 patients (control group). The HXA group achieved a significantly lower incidence of postoperative CSF leakage than the control group (0% vs. 26.3%, p = 0.016). No HXA-related complications were observed. The use of injectable HXA in skull base reconstruction was highly effective and safe. This technique and its favorable results might be readily reproduced by less-experienced neurosurgeons.
- Open Access
- 1 January 2023
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 19 (3) , 403-404
Letter to the Editor: Is the Glucose/Potassium Ratio Reliable to Predict Patient Outcomes for Traumatic Brain Injury?
Kim KH. Korean J Neurotrauma. 2023 Sep;19(3):403-404. https://doi.org/10.13004/kjnt.2023.19.e46
- 1 January 2023
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 19 (3) , 403-404
Open AccessLetter to the Editor: Is the Glucose/Potassium Ratio Reliable to Predict Patient Outcomes for Traumatic Brain Injury?
Kim KH. Korean J Neurotrauma. 2023 Sep;19(3):403-404. https://doi.org/10.13004/kjnt.2023.19.e46
- Open Access
- 1 January 2023
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 19 (3) , 288-297
Medical Management of Chronic Subdural Hematoma
Kim KH, et al. Korean J Neurotrauma. 2023 Sep;19(3):288-297. https://doi.org/10.13004/kjnt.2023.19.e47
- 1 January 2023
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 19 (3) , 288-297
Open AccessMedical Management of Chronic Subdural Hematoma
Kim KH, et al. Korean J Neurotrauma. 2023 Sep;19(3):288-297. https://doi.org/10.13004/kjnt.2023.19.e47